Vision-Sciences, Inc. (VSCI) Announces Peer-Reviewed Publication of Clinical Study Utilizing Its EndoSheath(R) Technology to Diagnose Esophageal Disease  
5/18/2012 10:05:01 AM

ORANGEBURG, N.Y., May 17, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced positive findings from a 426-patient multi-center research study evaluating the feasibility, safety, acceptability, and yield of unsedated transnasal esophagoscopy (TNE) using Vision-Sciences' EndoSheath technology to diagnose esophageal neoplasia. The study, entitled "Feasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy," was published in the May 2012 issue of the peer-reviewed journal Gastrointestinal Endoscopy.